Page last updated: 2024-09-03

imatinib mesylate and Cancer of Paranasal Sinus

imatinib mesylate has been researched along with Cancer of Paranasal Sinus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agaimy, A; Bonekamp, D; Brors, B; Dieter, SM; Ehrenberg, KR; Eils, R; Federspil, PA; Fröhlich, M; Fröhling, S; Glimm, H; Gröschel, S; Heining, C; Huebschmann, D; Hutter, B; Jung, CS; Kriegsmann, M; Mavratzas, A; Penzel, R; Reuss, DE; Schirmacher, P; Schlemmer, HP; Schlesner, M; Scholl, C; Stenzinger, A; von Kalle, C; Weichert, W; Wolf, S	1

Other Studies

1 other study(ies) available for imatinib mesylate and Cancer of Paranasal Sinus

Article	Year
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 01-01, Volume: 28, Issue:1 Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma; DNA Mutational Analysis; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Humans; Imatinib Mesylate; Immunohistochemistry; Male; Mutation; Paranasal Sinus Neoplasms; Proto-Oncogene Proteins c-kit	2017

Article

Year

Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 01-01, Volume: 28, Issue:1

Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma; DNA Mutational Analysis; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Humans; Imatinib Mesylate; Immunohistochemistry; Male; Mutation; Paranasal Sinus Neoplasms; Proto-Oncogene Proteins c-kit

2017